Elizabeth Garner Net Worth

Elizabeth Garner biography

Dr. Elizabeth Garner M.D. serves as Independent Director of the Company. Dr. Garner has over a decade of pharmaceutical development experience, holding roles of increasing strategic responsibility in large and small companies, including Merck, Abbott (AbbVie), Myriad Genetics and Agile Therapeutics. Dr. Garner has served as the Chief Medical Officer at ObsEva SA, a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health since July 2019. From January 2014 to July 2019, Dr. Garner was Chief Medical Officer of Agile Therapeutics, Inc., a public women’s healthcare company, and led the company’s clinical development, regulatory, and medical affairs strategies. Prior to her tenure at Agile, Dr. Garner was Vice President, Medical Affairs, Women’s Health/Preventive Care at Myriad Genetics from 2012 to 2014. Before that, she was Senior Director at Abbott Laboratories. From 2007 to 2011, Dr. Garner was Associate Director and then Director, Clinical Research at Merck Research Laboratories. Dr. Garner received joint M.D. and M.P.H degrees from Harvard Medical School and the Harvard School of Public Health. She was trained in obstetrics and gynecology at Brigham and Women’s/Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at Brigham and Women’s and Dana Farber Cancer Institute. Prior to entering the pharmaceutical industry, Dr. Garner had several years of experience in academic clinical practice, basic science research in ovarian cancer, and teaching and mentorship at Harvard Medical School. She is also an author on numerous peer-reviewed scientific papers. Garner’s business and leadership experience at life sciences companies and her medical and scientific background qualifies her to serve on our Board.

What is the salary of Elizabeth Garner?

As the Independent Director of Kezar Life Sciences Inc, the total compensation of Elizabeth Garner at Kezar Life Sciences Inc is $38,928. There are 11 executives at Kezar Life Sciences Inc getting paid more, with John Fowler having the highest compensation of $3,532,020.

How old is Elizabeth Garner?

Elizabeth Garner is 52, he's been the Independent Director of Kezar Life Sciences Inc since 2019. There are 6 older and 8 younger executives at Kezar Life Sciences Inc. The oldest executive at Kezar Life Sciences Inc is Franklin Berger, 70, who is the Independent Director.

What's Elizabeth Garner's mailing address?

Elizabeth's mailing address filed with the SEC is C/O KEZAR LIFE SCIENCES, INC., 4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Kezar Life Sciences Inc

Over the last 6 years, insiders at Kezar Life Sciences Inc have traded over $3,836,099 worth of Kezar Life Sciences Inc stock and bought 6,372,267 units worth $30,891,130 . The most active insiders traders include Venture Investments Ltd Mor..., Asset Management, Lp Chen B..., and Franklin M Berger. On average, Kezar Life Sciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of $91,954. The most recent stock trade was executed by Mark C. Schiller on 2 July 2024, trading 6,688 units of KZR stock currently worth $3,879.

What does Kezar Life Sciences Inc do?

kezar life sciences, inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the united states. the company's lead product candidate is kzr-616, a selective immunoproteasome inhibitor that is in phase 2 clinical trials across five autoimmune indications, including lupus nephritis, autoimmune hemolytic anemia, immune thrombocytopenia, dermatomyositis, and polymyositis; and phase 1b/2 clinical trials in systemic lupus erythematosus and lupus nephritis. its preclinical products include kzr-616, a selective immunoproteasome inhibitor for the treatment of various autoimmune disease indications; and kzr-tbd for the treatment of oncology and autoimmunity. the company was founded in 2015 and is headquartered in south san francisco, california.

Kezar Life Sciences Inc executives and stock owners

Kezar Life Sciences Inc executives and other stock owners filed with the SEC include:

• John Fowler,
  Chief Executive Officer, Director
• Christopher Kirk,
  President, Chief Scientific Officer, Director
• Marc Belsky,
  Chief Financial Officer, Secretary
• John Franklin Fowler,
  Co-Founder, CEO & Director
• Dr. Noreen Roth Henig,
  Chief Medical Officer
• Dr. Christopher J. Kirk,
  Co-Founder, Pres, Chief Scientific Officer & Director
• Jean-Pierre Sommadossi,
  Independent Chairman of the Board
• Graham Cooper,
  Independent Director
• Michael Kauffman,
  Independent Director
• Franklin Berger,
  Independent Director
• Jason Dinges,
  Independent Director
• Elizabeth Garner,
  Independent Director
• Alex Gray,
  IR Contact Officer
• Noreen Henig,
  Chief Medical Officer
• Vassiliki Economides,
  Senior Vice President - Strategy and External Affairs
• Vassiliki Economides,
  Sr. VP of Strategy & External Affairs
• Gitanjali Jain,
  VP of Investor Relations & External Affairs
• Michael Wolfe,
  Director of Fin. & Operations
• Marc L. Belsky,
  CFO & Sec.
• Dr. Jack Taunton Ph.D.,
  Co-Founder
• Talent Investments Ltd Equal,
  10% owner
• Management Company, Llc Abe...,
  10% owner
• Arthur Ma.M. Pappas Life Sc...,
  
• Fund Iv, L.P.Omega Fund Iv ...,
  
• Asset Management, Lp Chen B...,
  
• Venture Investments Ltd Mor...,
  
• Ventures, Inc.Chiesi Ventur...,
  
• Therapeutics, Inc.Amgen Inc...,
  
• City Capital Llc Bay,
  10% owner
• Thomas F Steyer,
  
• Niti Goel,
  Chief Medical Officer
• Mark C. Schiller,
  Chief Legal Officer
• Nicholas Michael Mordwinkin,
  Chief Business Officer
• Micki Klearman,
  
• Courtney Wallace,